OpenAI backs a new venture trying to thwart AI bio attacks
2025-10-24
Economic Times
The information displayed in the AIM should not be reported as representing the official views of the OECD or of its member countries.
OpenAI, alongside Founders Fund and Lux Capital, has invested $30 million in New York-based startup Valthos. Valthos is developing AI-powered software to detect and counter potential AI-engineered biological threats, aiming to prevent future bioweapon attacks enabled by advances in artificial intelligence. No actual incident has occurred yet.[AI generated]
Why's our monitor labelling this an incident or hazard?
The article explicitly involves AI systems used for biosecurity and bioweapon threat detection, which is a clear AI system involvement. No actual harm or incident has occurred yet; rather, the article discusses the potential for AI to be misused to create bioweapons, which is a plausible future harm. The startup's efforts to counter this threat do not negate the underlying hazard. Hence, the event is best classified as an AI Hazard, reflecting the credible risk of AI-enabled bioweapon attacks and the emerging efforts to mitigate that risk.[AI generated]